Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Hisamitsu Pharm CO Ltd (HTSUF)

Hisamitsu Pharm CO Ltd (HTSUF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.59
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.5000 unch
on 08/08/19
38.5000 unch
on 08/08/19
N/A (-6.33%)
since 05/29/19
3-Month
38.5000 unch
on 08/08/19
41.1000 -6.33%
on 05/29/19
-2.6000 (-6.33%)
since 05/25/17

Most Recent Stories

More News
U.S. FDA Approves SECUADO(R) (asenapine) Transdermal System, the First-and-Only Transdermal Patch for the Treatment of Adults with Schizophrenia

Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Administration (FDA) has approved SECUADO (R) (asenapine) transdermal...

HTSUF : 38.5000 (-6.33%)
NOVN : 2.35 (+0.86%)
Noven Announces Appointment of Dr. Naruhito Higo as Chief Executive Officer

Noven Pharmaceuticals, Inc. today announced its decision to appoint Dr. Naruhito Higo as Chief Executive Officer effective October 1, 2019, succeeding Jeff Mihm who has tendered his resignation. Noven...

HTSUF : 38.5000 (-6.33%)
NOVN : 2.35 (+0.86%)
Noven Announces Appointment of Andrew J. Purcell as Head of Marketing & Sales

Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Japan-based Hisamitsu Pharmaceutical Co., Inc., announced the appointment of Andrew J. Purcell as Noven's Head of Marketing & Sales.

HTSUF : 38.5000 (-6.33%)
NOVN : 2.35 (+0.86%)
Hisamitsu America, Marketers of the Salonpas Line of Pain- Relieving Products, Announce Availability of Salonpas-Hot in New 3-Count Value Pack

Hisamitsu America, a division of Hisamitsu Pharmaceutical Co., Inc., and the marketers of the Salonpas line of pain-relieving products, announce the availability of Salonpas-HOT (SRP: $5.99), the top-selling...

HTSUF : 38.5000 (-6.33%)
Trade HTSUF with:

Key Turning Points

2nd Resistance Point 38.5000
1st Resistance Point 38.5000
Last Price 38.5000
1st Support Level 38.5000
2nd Support Level 38.5000

See More

52-Week High 41.1000
Fibonacci 61.8% 40.1068
Fibonacci 50% 39.8000
Fibonacci 38.2% 39.4932
Last Price 38.5000
52-Week Low 38.5000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar